Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
08/2003
08/12/2003US6605599 Epothilone derivatives
08/07/2003WO2003064432A1 Process for total synthesis of ecteinascidins and intermediates therefor
08/07/2003WO2003064428A1 Furano- and thienopyrimidines as neurokinase inhibitors
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064422A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
08/07/2003WO2003064421A1 Aminopiperidine derivatives
08/07/2003WO2003064413A1 Quinazoline compounds
08/07/2003WO2003064406A1 Resistance-repellent retroviral protease inhibitors
08/07/2003WO2003064389A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063779A2 Selective analgesic agents
08/07/2003WO2002048150A3 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/07/2003US20030149278 Method for preparing (+)-biotine
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149069 Tetrahydroquinoline derivatives that are useful for cancer chemotherapy and anti-viral applications
08/07/2003US20030149065 Arylkylamine spirofuropyridines useful in therapy
08/07/2003US20030149046 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
08/07/2003US20030149036 Substituted benzothiazole amide derivatives
08/07/2003US20030149029 Administering to a mammal indole derivative compound for therapy of asthma
08/07/2003US20030149017 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc.
08/07/2003US20030148967 For prophylaxis and therapy of viral infection for example by varicella zoster virus (VZV)
08/07/2003CA2474850A1 Imidazo[1,2-a]pyridine derivatives
08/07/2003CA2474434A1 Condensed heterocyclic compounds
08/07/2003CA2474306A1 Selective analgesic agents
08/07/2003CA2473231A1 Resistance-repellent retroviral protease inhibitors
08/07/2003CA2466915A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/06/2003EP1332143A1 Polysubstituted imidazopyridines as gastric secretion inhibitors
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003CN1434046A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434044A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434043A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434037A Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/05/2003US6602898 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602871 Thrombin or factor Xa inhibitors
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003US6602248 Methods for repairing damaged intervertebral discs
08/05/2003CA2088798C Condensed imidazopyridine derivatives
07/2003
07/31/2003WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003032911A3 Anti-angiogenic and cytotoxic fused pyrimidines
07/31/2003US20030144515 Process for making spirolactone compounds
07/31/2003US20030144509 Prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients.
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144323 Phenylalkynes
07/31/2003US20030144319 2-Substituted piperidine analogs as excitatory amino acid receptor antagonists that block N-methyl-D-aspartic acid receptors; neuroprotective agents; stroke; brain disorders; antiischemic agents; anxiolytic agents; headaches; analgesics
07/31/2003US20030144304 Novel hexacyclic compounds
07/31/2003US20030144297 Substituted aryl 1,4-pyrazine derivatives
07/31/2003US20030144282 Inhibitors of cytosolic phospholipase A2
07/31/2003US20030144246 Chromenylmethyl pyrimidinediamines as antibacterial agents
07/31/2003US20030144175 Protease inhibitors
07/31/2003CA2473796A1 Substituted quinazolin-4-ylamine analogues
07/31/2003CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/30/2003EP1331223A1 Method of treating sepsis
07/30/2003CN1433310A Medicinal compositions containing camptothecin derivative and regulating agent
07/30/2003CN1432571A Pyridone compound and its prepn process
07/30/2003CN1116291C Substituted tetracyclic tetrahydrofuran derivatives
07/29/2003US6600043 Carboxylic acid derivatives, their preparation and use
07/29/2003US6600036 Treating diseases of the central nervous system.
07/29/2003US6599915 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxinol[2,3f]quinoline
07/24/2003WO2003059913A1 Roh-kinase inhibitors
07/24/2003WO2003059911A2 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS
07/24/2003WO2003059910A1 Intermediates for preparing glycogen phosphorylase inhibitors
07/24/2003WO2003059892A1 Substituted alkyl uracils and the use thereof
07/24/2003WO2003059335A1 Phenyl sulfoxides and phenyl sulfones
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents
07/24/2003US20030139431 Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors
07/24/2003US20030139412 Gastrointestinal disorders
07/24/2003US20030139397 Pesticides
07/24/2003US20030139388 Antiinflammatory agents; osteoporosis
07/24/2003US20030138791 3-Spiro-cyanin fluorochromes and their use in bioassays
07/24/2003CA2474127A1 4-oxo-4, 7-dihydrofuro¬2,3-b|pyridine-5-carboxamide antiviral agents
07/24/2003CA2473374A1 Phenyl sulfoxides and phenyl sulfones
07/24/2003CA2473362A1 Substituted alkyl uracils and the use thereof
07/24/2003CA2472619A1 Fused pyrimidine derivates as rho-kinase inhibitors
07/24/2003CA2472205A1 Intermediates for preparing glycogen phosphorylase inhibitors
07/23/2003EP1328527A1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
07/23/2003EP0983274B1 Phthalocyanine and use of phthalocyanine as a marking agent
07/23/2003CN1432011A Benzoamide piperidine compounds as substance P antagonists
07/23/2003CN1431996A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
07/23/2003CN1431904A Protease inhitors
07/23/2003CN1115344C Substituted phenyl keto enols derivatives, its prepn. method and use
07/23/2003CN1115146C Use of rifaximin in treatment of diarrhoea from cryptosporidiosis
07/22/2003US6596873 2-and 2,5-substituted phenylketoenols
07/22/2003US6596746 Cyclic protein tyrosine kinase inhibitors
07/22/2003US6596727 Substituted pyrimidines, processes for their preparation, and their use as pesticides and fungicides
07/22/2003US6596726 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme
07/17/2003WO2003057694A1 Method for producing scopine esters
07/17/2003WO2003057220A1 Cyclic urea derivatives with 5-ht2c receptor activity
07/17/2003WO2003057173A2 Broad spectrum inhibitors
07/17/2003WO2003057161A2 BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF
07/17/2003WO2003008410A3 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression
07/17/2003US20030135049 Preparing camptothecin intermediates
07/17/2003US20030135045 Glycoprotein IIb/IIIa antagonists
07/17/2003US20030134883 Use in the treatment of cancer and other diseases characterized by undesired cellular hyperproliferation.
07/17/2003US20030134870 Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4]dioxino-[2,3-e]indole
1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 298